Wei Foong Lim
Director/Board Member at BIONEXUS GENE LAB CORP.
Net worth: 299 230 $ as of 2024-04-29
Profile
Wei Foong Lim is currently the Director at Chemrex Corp.
Sdn.
Bhd.
He is also an Independent Non-Executive Director at EVD Bhd.
starting in 2024 and a Director at BioNexus Gene Lab Corp.
starting in 2023.
Mr. Lim completed his undergraduate degree at Western Michigan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIONEXUS GENE LAB CORP
2.84% | 2024-04-15 | 504,603 ( 2.84% ) | 299 230 $ | 2024-04-29 |
Wei Foong Lim active positions
| Companies | Position | Start |
|---|---|---|
| BIONEXUS GENE LAB CORP. | Director/Board Member | 2023-12-10 |
| EVD | Director/Board Member | 2024-02-21 |
Chemrex Corp. Sdn. Bhd.
 Chemrex Corp. Sdn. Bhd. Wholesale DistributorsDistribution Services Part of BioNexus Gene Lab Corp., Chemrex Corp. Sdn. The private company is based in Cheras, Malaysia. Bhd. is a Malaysian company that wholesales chemicals and resins. Chemrex Corp. Sdn. The CEO of the company is Chan Chong Wong. was acquired by BioNexus Gene Lab Corp. on December 31, 2020 for $133.14 million. | Director/Board Member | - |
Training of Wei Foong Lim
| Western Michigan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EVD | Technology Services |
| Private companies | 2 |
|---|---|
Chemrex Corp. Sdn. Bhd.
Chemrex Corp. Sdn. Bhd. Wholesale DistributorsDistribution Services Part of BioNexus Gene Lab Corp., Chemrex Corp. Sdn. The private company is based in Cheras, Malaysia. Bhd. is a Malaysian company that wholesales chemicals and resins. Chemrex Corp. Sdn. The CEO of the company is Chan Chong Wong. was acquired by BioNexus Gene Lab Corp. on December 31, 2020 for $133.14 million. | Distribution Services |
| BioNexus Gene Lab Corp. |
- Stock Market
- Insiders
- Wei Foong Lim